Press release
Investigation announced for Investors in shares of Vaxart, Inc. (NASDAQ: VXRT)
An investigation for investors in Vaxart, Inc. (NASDAQ: VXRT) shares over potential securities laws violations by Vaxart, Inc.
Investors who purchased shares of Vaxart, Inc. (NASDAQ: VXRT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Vaxart, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
San Francisco, CA based Vaxart, Inc., a clinical-stage company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. Vaxart, Inc. reported that its annual Total Revenue rose from $4.15 million in 2018 to $9.86 million in 2019, and that its Net Loss increased from $18 million in 2018 to $18.64 million in 2019.
Shares of Vaxart, Inc. (NASDAQ: VXRT) rose from $0.36 per share in January 2020 to as high as $17.15 per share on July 16, 2020.
Since then shares of Vaxart, Inc. (NASDAQ: VXRT) declined to $12.00 per share on July 24, 2020.
Those who purchased shares of Vaxart, Inc. (NASDAQ: VXRT) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Vaxart, Inc. (NASDAQ: VXRT) here
News-ID: 2097473 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Vaxart
Norovirus Vaccine Market to Signify Strong Growth by 2024-2030 | Hillevax, Vaxar …
A new Report by Infinity Business Insights, titled "Norovirus Vaccine Market": Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2030, offers a comprehensive analysis of the industry, which comprises insights on the Norovirus Vaccine market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
Market Overview of Norovirus Vaccine Market: The Norovirus Vaccine market is witnessing significant growth due to the rising prevalence of norovirus…
Vaxart, Inc. (NASDAQ: VXRT) Shareholder Notice: Update in Lawsuit
The Shareholders Foundation announced an update in the lawsuit that was filed for certain investors in shares of Vaxart, Inc. (NASDAQ: VXRT).
Investors who purchased shares of Vaxart, Inc. (NASDAQ: VXRT) prior to June 15, 2020 and continue to hold any of those shares, have also certain options. Those NASDAQ: VXRT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On August 24, 2020, a…
Vaccines Delivery Market Is Booming Worldwide | Echo Therapeutics, Novavax, BioC …
Global Vaccines Delivery Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Vaccines Delivery Market. Some of the key…
Investigation announced for Investors in Vaxart, Inc. (NASDAQ: VXRT)
Certain directors of Vaxart, Inc are under investigation over potential breaches of fiduciary duties.
Investors who purchased shares of Vaxart, Inc. (NASDAQ: VXRT) and currently hold any of those Vaxart, Inc. (NASDAQ: VXRT shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Vaxart, Inc. directors breached their fiduciary duties and caused damage to the…
Investigation announced for Long-Term Investors in shares of Vaxart, Inc. (NASDA …
An investigation was announced for current long-term investors in shares of Vaxart, Inc. (NASDAQ: VXRT) concerning potential breaches of fiduciary duties by certain directors of Vaxart, Inc.
Investors who are current long term investors in Vaxart, Inc. (NASDAQ: VXRT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: VXRT stocks…
Lawsuit filed for Investors in shares of Vaxart, Inc. (NASDAQ: VXRT)
An investor, who purchased shares of Vaxart, Inc. (NASDAQ: VXRT), filed a lawsuit i over alleged violations of Federal Securities Laws by Vaxart, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Vaxart, Inc. (NASDAQ: VXRT) have certain options and for certain investors are short and strict deadlines running. Deadline: October 23, 2020. NASDAQ: VXRT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call…
